Looking to publish in mAbs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginmAbs is a multidisciplinary open access journal dedicated to antibody research and development. It covers topics including engineering and selection of antibody therapeutics, machine learning and artificial intelligence applications, non-clinical antibody studies, manufacturing and formulation, regulatory review of antibody therapeutics, and post-approval market topics, and serves scientific, medical, technology transfer, legal, investment, planning, and therapeutics regulation audiences.
Looking to publish in mAbs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
mAbs accepts the following article types. Click on an article type to view submission instructions.
Research Articles
Reviews
Brief Reports
Short Communications
Recent Publications
Bispecific antibodies that engage pIgR enrich in mucosa in cynomolgus monkeys
Kelsie Marks, Nirav Shah, Ly Pham, Jun Chen, Ian White, Krista Burke, Peter Garrett, Mathieu Marella, Prathap Nagaraja Shastri, Brian Geist, Partha Chowdhury, Vinicius Carreira, Wan Cheung Cheung, Adam Zwolak
NanoSaurus: addressing the urgent need for open access in single-domain antibody research
P. Di Filippo, E. Pardon, R.J. Owens, F.I. Schmidt, C. Durinx, U. Rothbauer, H. Ploegh, M. A. Seeger, S. Muyldermans, W. Vranken, J. Steyaert
Near pan-alphavirus neutralization by an antibody-nanobody bispecific
Sergei Pletnev, Christina L. Gardner, Matthew S. Sutton, Baoshan Zhang, Victoria Callahan, Courtney Green, Nicholas C. Morano, Tatsiana Bylund, Megan M. Dunagan, Yaroslav Tsybovsky, Ellen R. Goldman, Lawrence Shapiro, Crystal W. Burke, Julie M. Fox, Mario Roederer, Peter D. Kwong, Tongqing Zhou
Predicting non-specific binding of VHHs using machine learning models with cluster-aware validation
Valentin Stanev, Federico Devalle, Mehdi Boroumand, Maryam Pouryahya, Isabelle Sermadiras, Jenna Caldwell, Kuan-Lin Chen, Jay Hyun Jo, Rohan Jain, Bismark Amofah, Tony Pham, Mark Hutchinson, Sharfa Farzandh, Jen DiChiara, Chacko Chakiath, Tom Diethe, Andrew Dippel, Gilad Kaplan, Rebecca Croasdale-Wood
A framework for evaluating unexpected reactions in antibody-drug conjugates during clinical development: a case study of a promiscuous payload
Eef H. C. Dirksen, Marijn Buurman, Jeroen Kooistra, Benno Ingelse, Ruud Ubink
Frequently asked questions
How long does it take to publish?
13 days average from submission to first decision; 27 days average from submission to first post-review decision; 11 days average from acceptance to online publication.
Reformat to mAbs using Livewrite PremiumWhat are the publication costs?
Open access publication may be covered by an institutional open access agreement; specific APC amounts are not stated.
Reformat to mAbs using Livewrite Premium